Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Standard BioTools Inc. (LAB) had Income from Continuous Operations of $-58.83M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$85.33M |
|
$-74.90M |
|
$42.79M |
|
$42.54M |
|
$195.58M |
|
$-110.25M |
|
$13.55M |
|
$-96.70M |
|
$-96.70M |
|
$-58.83M |
|
|
Income from Continuous Operations |
$-58.83M |
$-74.90M |
|
$-58.83M |
|
$-110.25M |
|
$-101.92M |
|
381.62M |
|
381.62M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$454.26M |
|
$19.27M |
|
$113.49M |
|
$567.75M |
|
$108.31M |
|
$0.30M |
|
$35.16M |
|
$143.46M |
|
$424.29M |
|
$424.29M |
|
$424.29M |
|
386.38M |
|
| Cash Flow Statement Financials | |
$-74.34M |
|
$27.41M |
|
$0.57M |
|
$168.82M |
|
$123.30M |
|
$-45.52M |
|
$29.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.19 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
49.86% |
|
-129.20% |
|
-129.20% |
|
-119.44% |
|
-113.33% |
|
-87.77% |
|
$-82.65M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
2.14 |
|
6.35 |
|
57.45 |
|
-13.86% |
|
-13.86% |
|
-10.36% |
|
-13.85% |
|
$1.10 |
|
$-0.22 |
|
$-0.19 |
|